FCI

FCI Ophthalmics is a well-established, privately held leader in the ophthalmic medical device sector, with a 40-year history of innovation. The company's strength lies in its broad and deep portfolio of surgical tools and implants, particularly in lacrimal and dry eye management, where it offers differentiated products like the SnugPlug® and LacriJet®. Operating globally through regional divisions (FCI Worldwide, FCI Ophthalmics for US/Canada, FCI France), FCI serves ophthalmologists and oculoplastic surgeons by converting complex surgical cases into simpler procedures with its specialized devices. Its business model is commercial, generating revenue from the sale of its approved medical devices.

Expertise in design and manufacturing of specialized ophthalmic surgical devices, with a focus on minimally invasive, preloaded, and self-retaining systems using various biomaterials like silicone and porous polyethylene.

FCI competes in the ophthalmic device market against large, integrated players like Alcon, J&J Vision, and Bausch + Lomb, as well as other specialist firms. Its competitive advantage lies in its deep specialization, particularly in lacrimal and dry eye devices, and its history of clinician-driven innovation for procedural simplification.